Anika Reports First Quarter 2019 Financial Results

16:05 EDT 2 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Total Revenue Increased 16% Year-over-Year Solid Bottom Line Performance with $0.31 Diluted EPS New Leadership Added to Accelerate Innovation and Expand Commercial Reach Announces $50 Million Sh...

Other Sources for this Article

Anika Therapeutics, Inc.
Joseph Darling, President & CEO

Sylvia Cheung, CFO
Tel: 781-457-9000


More From BioPortfolio on "Anika Reports First Quarter 2019 Financial Results"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...